FindTrial
Sign In

Role of L.M potency in treatment of Atopic Dermatitis.

Usefulness of fifty millesimal potency in management of Atopic Dermatitis in young adults: An exploratory study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065968
Enrollment
31
Registered
2024-04-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Homeopathic Medicine: Oral root of administration Medicine used in liquid form L.M potency first dose is given after taking the case Subsequent doses after each followup Potency accordi

Sponsors

Bakson Homoeopathic medical college and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group from 15 to 24 years for both genders Diagnosed patients by Hanifin and Rajka criteria History of recurrence of disease in past 5 years

Exclusion criteria

Exclusion criteria: Any other dermatological condition associated with Atopic Dermatitis Any bacterial or viral infections Patients with psychiatric diseases Patient who are not able to comply to the study protocol

Design outcomes

Primary

MeasureTime frame
It is expected to have positive changes on EASI Scale.Timepoint: EASI scale will be performed at 4th 8th 12th upto 24th week—

Secondary

MeasureTime frame
NILTimepoint: Not applicable—

Countries

India

Contacts

Public ContactDr CP Sharma

Bakson Homeopathic Medical College And Hospital

manisharauniyar121@gmail.com9097866786

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026